Category: National Institute of Health
FOR IMMEDIATE RELEASE: Date: 1/27/10
Contact:
Angus G. McQuilken
Vice President for Communications
Cell: 617-921-7749
amcquilken@masslifesciences.com
$3 million available to match federal grant funding for early-stage life sciences companies
Waltham, Massachusetts –The Massachusetts Life Sciences Center, a quasi-public agency tasked with implementing the state’s ten year, $1 billion Life Sciences Initiative, today launched a new Small Business Matching Grant (SBMG) program that will match federal small business grant funding for early-stage life sciences companies in Massachusetts. $3 million will be made available for the program for Fiscal Year 2010. The Center will begin accepting on-line applications for the new program on Monday, February 1, 2010. Applications will be submitted via the Center’s web site at www.masslifesciences.com.
 |
|
Grantwriting 101
including SBIR and STTRs
|
|
qed@qb3 - UCB
Friday, February 5, 2010
12:00 to 1:00 pm
Stanley Hall Room 621
|
SBIR/STTR grants can provide the critical funding necessary to launch your company. But success requires mastering the tricks of the SBIR/STTR program, some of which have frustrated excellent groups. From where to register to uploading your proposal, we'll cover the ins and outs of preparing grants for the NIH. This seminar is aimed at new and experienced grantwriters, from academia and industry. Even veteran grantwriters will benefit from a review of the new formats required as of January 2010.
Shauna Farr-Jones has a 10-year record of writing successful government grant and contract proposals on diverse life science topics, providing strategic input on both research and business plans. She has helped companies secure over $125 million in grant and contract funding from government and philanthropic agencies. Previously, she was at BioCentury Publications, where she analyzed the biotechnology industry. She was a postdoc in PharmChem at UCSF after a Ph.D. in Biochem from Tufts.
Amy F. Boggs is an independent consultant with more than 8 years experience in grant-writing. She also handles the preparation of technical reports, INDs and NDAs, technology assessment, strategic research planning, and competitive landscaping. Prior, Dr. Boggs worked at Microcide and at IntraBiotics, where she managed an interdisciplinary technology in-licensing team. Dr. Boggs is an inventor on three issued patents and has worked on IND-enabling projects. She completed a Ph.D. in PharmChem at UCSF under Dr. Agard.
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=197134
Date: January 21, 2010
Time: 1:00PM-3:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
You may have been a master of grant writing, but things are about to change! The NIH is unrolling a shortened and restructured format for grants starting in 2010. All applications for due dates on or after January 25, 2010 require use of new forms and new instructions. New instructions mean shorter page limits! The research plan is fully restructured and reflects new evaluation criteria. Even people who have written grants in the past are going to need to “relearn” the process. Join us for an interactive workshop on grant writing basics and pitfalls. This event will cover general submissions and writing strategies, with a special focus on NIH SBIRs new submission format, as well as other agencies, grants, and deadlines. | Registration fee: from $0 to $40 | 1:00-3:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Gregory Milman, Ph.D., Director of the Office for Innovation and Special Programs in NIAID
Also: A panel discussion by award winners
2-4 pm on January 13 in Byers Auditorium, Genentech Hall
Reception to follow in the atrium
SBIR and STTR funding can provide critical early stage support for successful bioscience companies. Indeed, many of the companies in the QB3 Mission Bay Incubator Network used SBIR funding to move from lab to startup. This seminar will unpack the secrets of what it takes to maximize your chances of success. Greg Milman oversees the NIAID’s $100M/year SBIR and STTR program.
Contact
Jeanne Mell
University City Science Center
215-966-6029
PHILADELPHIA--(December 21, 2009) – Lisa Staiano-Coico of Temple University has joined the University City Science Center’s Board of Directors. Dr. Staiano-Coico is Provost and Executive Vice President for Academic Affairs, and Professor of Surgery at Temple University.
A widely published expert in skin cell biology, wound healing and burns, Dr. Staiano-Coico has held appointments as professor of nutritional sciences, professor of fiber science and apparel design, professor of microbiology in surgery, professor of public health, and professor of microbiology in dermatology. Prior to coming to Temple, she was dean of the College of Human Ecology at Cornell University. Her research has been funded by the National Institutes of Health (NIH), the New York Firefighters Burn Center Foundation and other agencies.
Philadelphia, PA. November 1, 2009 /BUSINESS WIRE/--Integral Molecular, Inc. has been selected to receive a five year, $9.1 million contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, to elucidate novel B cell epitopes on the surface of viral pathogens.
Collaboration with Biomodels facilitates development of novel drug product
BURLINGTON, MA (Sept. 16) Avaxia Biologics, Inc., a biotechnology company developing oral antibodies for disease targets accessible via the GI tract, announced today that it has been awarded a Phase I SBIR grant from the National Institute of Dental and Craniofacial Research to support the development of a novel antibody therapeutic for oral mucositis.
Cumberland Emerging Technologies (CET) is a joint initiative between Cumberland Pharmaceuticals, Vanderbilt University and Tennessee Technology Development Corporation (TTDC). CET provides commercialization services to organizations looking to secure intellectual property, license and transfer technology, and commercialize novel technologies. In addition to providing these services to universities, hospitals and businesses in the Cumberland area, CET also provides physical resources and lab space to small companies who also may make use of CET's business services.
When I last spoke with Massachusetts Life Sciences Center, President and CEO, Susan Windham-Bannister, the Center was in the midst of celebrating their one year anniversary of the $1 billion, ten year initiative. In 2008 The Center invested $46 million and leveraged an additional $350 million in public and private funds. Since June, the Center has been fairly busy. They have:
• Continued funding for the International Stem Cell Registry.
• Announced the awarding of New Investigator Matching Grants to 10 young scientists.
• Matched 104 interns with 59 life sciences companies within the Commonwealth with The Center’s Internship Challenge.
Just the other day I spoke with Angus McQuilken, Vice President for Communications at Massachusetts Life Sciences Center. We talked about the Center, and the recent initiatives that they have been pursuing. He said that additional investment of $695,000 in the International Stem Cell Registry is a supplement to last year’s investment of $570,000. Since the Obama administration has lifted restrictions on federal funding for embryonic stem cell research and Congress has appropriated $8 billion in NIH research grants; when you combine this recent investment with the $7.7 million investment in the Massachusetts Stem Cell Bank, Massachusetts is very well positioned to compete for federal funds.
Massachusetts Life Sciences Center has also completed the second round of the New Investigator Matching Grants that seeks to support young scientists as they set up their labs and get their research underway. They have provided an additional 10 researchers with grants of up to $100,000 for the next two years that are matched dollar for dollar by the researcher's institution. Angus said that the Center is doing this to attract top scientists to Massachusetts and to keep good young scientists in the field, this second round is in addition to the grants from last year to 11 new investigators, so far assisting a total 21 researchers with $12 million coming from The Center and a total of $24 million when you include the matching funds.
In addition to those initiatives the Massachusetts Life Sciences Center has also started the Internship Challenge program matching college students in The Commonwealth with local life sciences companies and providing a stipend for the summer to those interns. 104 interns have been placed with 59 companies, Angus said, that the program has been more successful than anybody could have imagined. Many of these young companies don’t have the infrastructure to recruit interns for the summer, and the Center has created a user-friendly system where these companies can go out and find talent much more easily. The hope is that funding for the Massachusetts Life Sciences Center will increase by next year so that they will be able to continue and build upon their many initiatives, including the Internship Challenge, which is essential to ensuring a large, qualified workforce for The Commonwealth.
Angus said that the programs that they provide are really targeted at providing the supports that are needed for the Massachusetts life sciences industry. The Center is funding innovative young researchers, they are building new infrastructure to keep resources within The Commonwealth ahead of the game and they are making sure the supply of qualified workers remains overabundant. “The research has to take place so that research can be translated into commercialized products and therapies, so that those products and therapies can be brought to the marketplace,” Angus said. “Each step of the process creates an opportunity to create jobs and leverage private and federal investment in our state.” Angus continued, “Really our goal is to identify gaps where they exist and to help play a role in filling them, whether that be working capital for young companies, providing support for scientists, or helping companies and institutions find a way to collaborate so that translational research can go forward.”
We also talked about the Center providing support for the establishment of a Professional Science Masters Degree, University of Massachusetts has just received funding from The Sloan Foundation to expand on their operations in that area. This would provide a hybrid degree to increase the pool of people who have the expertise to address both scientific and business opportunities. In addition to the support of workforce development and support for the basic sciences, Massachusetts Life Sciences Center is currently reviewing the 84 applications to the tax incentive program. The Center is going to provide $25 million in tax incentives for life sciences companies; over the ten years of the initiative, that totals $250 million that The Center is going to be awarding. Those awards will be made on September 23, so we’ll just have to wait and see what comes next.
